ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
62,875.44
2.32%
S&P 500
5,222.68
0.16%
Dow Jones
39,512.84
0.32%
US Dollar vs Yen
155.8645
0.03%
Brent Oil
82.835
0.55%
Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NYSE
  6. Bio Rad Laboratories Inc (BIO.B)

  7. Bio Rad Laboratories Inc (BIO.B) ニュース

BIO.B

Bio Rad Laboratories (BIO.B)

Bio Rad Laboratories Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NYSE:BIO.B
日付受信時刻ニュースソース見出しコード企業名
2024/04/1822 : 00Business WireBio-Rad to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024NYSE:BIO.BBio Rad Laboratories Inc
2024/04/1105 : 15Business WireBio-Rad’s Chief Operating Officer Andrew Last to RetireNYSE:BIO.BBio Rad Laboratories Inc
2024/03/1122 : 59Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NYSE:BIO.BBio Rad Laboratories Inc
2024/03/0107 : 24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:BIO.BBio Rad Laboratories Inc
2024/02/2908 : 38Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:BIO.BBio Rad Laboratories Inc
2024/02/2908 : 24Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:BIO.BBio Rad Laboratories Inc
2024/02/2807 : 39Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:BIO.BBio Rad Laboratories Inc
2024/02/2807 : 35Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:BIO.BBio Rad Laboratories Inc
2024/02/2206 : 31Edgar (US Regulatory)Form 8-K - Current reportNYSE:BIO.BBio Rad Laboratories Inc
2024/02/1706 : 31Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NYSE:BIO.BBio Rad Laboratories Inc
2024/02/1606 : 24Edgar (US Regulatory)Form 8-K - Current reportNYSE:BIO.BBio Rad Laboratories Inc
2024/02/1606 : 15Business WireBio-Rad Reports Fourth-Quarter and Full-Year 2023 Financial ResultsNYSE:BIO.BBio Rad Laboratories Inc
2024/02/1507 : 01Edgar (US Regulatory)Form 8-K - Current reportNYSE:BIO.BBio Rad Laboratories Inc
2024/02/1407 : 00Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NYSE:BIO.BBio Rad Laboratories Inc
2024/01/3007 : 25Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NYSE:BIO.BBio Rad Laboratories Inc
2023/12/2002 : 19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:BIO.BBio Rad Laboratories Inc
2023/12/1501 : 40Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:BIO.BBio Rad Laboratories Inc
2023/12/1309 : 43Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:BIO.BBio Rad Laboratories Inc
2023/12/1308 : 24Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:BIO.BBio Rad Laboratories Inc
2023/12/0904 : 33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:BIO.BBio Rad Laboratories Inc
2023/12/0809 : 14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:BIO.BBio Rad Laboratories Inc
2023/12/0807 : 01Edgar (US Regulatory)Form 8-K - Current reportNYSE:BIO.BBio Rad Laboratories Inc
2023/12/0806 : 26Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:BIO.BBio Rad Laboratories Inc
2023/11/2907 : 48Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:BIO.BBio Rad Laboratories Inc
2023/11/2906 : 53Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:BIO.BBio Rad Laboratories Inc
2023/11/2905 : 48Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:BIO.BBio Rad Laboratories Inc
2023/11/0300 : 28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:BIO.BBio Rad Laboratories Inc
2023/10/2805 : 31Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:BIO.BBio Rad Laboratories Inc
2023/10/2805 : 31Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:BIO.BBio Rad Laboratories Inc
2023/10/2705 : 17Edgar (US Regulatory)Form 8-K - Current reportNYSE:BIO.BBio Rad Laboratories Inc
 Showing the most relevant articles for your search:NYSE:BIO.B

最近閲覧した銘柄

BIT
P34308
Bnp Paribas Issuance
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有